Region of Peptide 125-147 of Acetylcholine Receptor Alpha Subunit is Exposed at Neuromuscular Junction and Induces Experimental Autoimmune Myasthenia Gravis, T-cell Immunity, and Modulating Autoantibodies

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1985 Dec 1

PMID 3878521

Citations 18

Authors

V A Lennon

D J McCormick

E H LAMBERT

G E Griesmann

M Z Atassi

Affiliations

Soon will be listed here.

Abstract

A major antigenic region of native nicotinic acetylcholine receptors (AcChoR) has been identified by using a synthetic disulfide-looped peptide corresponding to alpha-subunit residues 125-147 of Torpedo electric organ AcChoR: Lys-Ser-Tyr-Cys-Glu-Ile-Ile-Val-Thr-His-Phe- Pro-Phe-Asp-Gln-Gln-Asn-Cys-Thr-Met-Lys-Leu-Gly. The peptide bound 26-56% of polyclonal antibodies induced in rat, rabbit, and dog by immunization with native AcChoR. Rats inoculated with 50 micrograms of unconjugated peptide developed helper T-cell responses, delayed hypersensitivity, and antibodies to native AcChoR. Anti-peptide antibodies were more reactive with native than denatured AcChoR and bound to the alpha subunit. Some reacted exclusively with mammalian muscle AcChoR, some induced modulation of AcChoR on cultured myotubes, but none inhibited binding of alpha-bungarotoxin to solubilized or membrane-associated AcChoR. Repeated immunization induced experimental autoimmune myasthenia gravis: clinical signs in one rat and electrophysiologic and/or biochemical signs in 10 of 11 rats. Thus, at least part of the corresponding region of the mammalian AcChoR alpha subunit is extracellular at the neuromuscular junction and a potential target for pathogenic autoantibodies in patients with acquired myasthenia gravis.

Citing Articles

Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations.

Dresser L, Wlodarski R, Rezania K, Soliven B J Clin Med. 2021; 10(11).

PMID: 34064035 PMC: 8196750. DOI: 10.3390/jcm10112235.

Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.

Moscato E, Jain A, Peng X, Hughes E, Dalmau J, Balice-Gordon R Eur J Neurosci. 2010; 32(2):298-309.

PMID: 20646055 PMC: 2955837. DOI: 10.1111/j.1460-9568.2010.07349.x.

Myasthenia gravis as a prototype autoimmune receptor disease.

Hoedemaekers A, Van Breda Vriesman P, De Baets M Immunol Res. 1997; 16(4):341-54.

PMID: 9439759 DOI: 10.1007/BF02786398.

Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.

Zhang G, Xiao B, Bakhiet M, van der Meide P, Wigzell H, Link H J Exp Med. 1996; 184(2):349-56.

PMID: 8760788 PMC: 2192725. DOI: 10.1084/jem.184.2.349.

Mapping the extracellular topography of the alpha-chain in free and in membrane-bound acetylcholine receptor by antibodies against overlapping peptides spanning the entire extracellular parts of the chain.

Atassi M, Mulac-Jericevic B J Protein Chem. 1994; 13(1):37-47.

PMID: 8011070 DOI: 10.1007/BF01891991.

References

Shibahara S, Kubo T, Perski H, Takahashi H, Noda M, Numa S . Cloning and sequence analysis of human genomic DNA encoding gamma subunit precursor of muscle acetylcholine receptor. Eur J Biochem. 1985; 146(1):15-22. DOI: 10.1111/j.1432-1033.1985.tb08614.x. View

Plumer R, Fels G, Maelicke A . Antibodies against preselected peptides to map functional sites on the acetylcholine receptor. FEBS Lett. 1984; 178(2):204-8. DOI: 10.1016/0014-5793(84)80601-8. View

Young E, Ralston E, Blake J, Ramachandran J, Hall Z, Stroud R . Topological mapping of acetylcholine receptor: evidence for a model with five transmembrane segments and a cytoplasmic COOH-terminal peptide. Proc Natl Acad Sci U S A. 1985; 82(2):626-30. PMC: 397094. DOI: 10.1073/pnas.82.2.626. View

McCormick D, Atassi M . Localization and synthesis of the acetylcholine-binding site in the alpha-chain of the Torpedo californica acetylcholine receptor. Biochem J. 1984; 224(3):995-1000. PMC: 1144538. DOI: 10.1042/bj2240995. View

LaRochelle W, Wray B, Sealock R, Froehner S . Immunochemical demonstration that amino acids 360-377 of the acetylcholine receptor gamma-subunit are cytoplasmic. J Cell Biol. 1985; 100(3):684-91. PMC: 2113498. DOI: 10.1083/jcb.100.3.684. View

McCormick D, Lennon V, Atassi M . Synthesis of an antigenic site of native acetylcholine receptor peptide 159-169 of Torpedo acetylcholine receptor alpha-chain. Biochem J. 1985; 226(1):193-7. PMC: 1144692. DOI: 10.1042/bj2260193. View

Criado M, Hochschwender S, Sarin V, Fox J, Lindstrom J . Evidence for unpredicted transmembrane domains in acetylcholine receptor subunits. Proc Natl Acad Sci U S A. 1985; 82(7):2004-8. PMC: 397474. DOI: 10.1073/pnas.82.7.2004. View

Momoi M, Lennon V . Evidence for structural dissimilarity in the neurotransmitter binding region of purified acetylcholine receptors from human muscle and Torpedo electric organ. J Neurochem. 1986; 46(1):76-81. DOI: 10.1111/j.1471-4159.1986.tb12927.x. View

Reiter M, Cowburn D, Prives J, Karlin A . Affinity labeling of the acetylcholine receptor in the electroplax: electrophoretic separtion in sodium dodecyl sulfate. Proc Natl Acad Sci U S A. 1972; 69(5):1168-72. PMC: 426655. DOI: 10.1073/pnas.69.5.1168. View

10.

Lennon V, Lindstrom J, Seybold M . Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs. J Exp Med. 1975; 141(6):1365-75. PMC: 2189842. DOI: 10.1084/jem.141.6.1365. View

11.

Lindstrom J, Einarson B, Lennon V, Seybold M . Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental.... J Exp Med. 1976; 144(3):726-38. PMC: 2190402. DOI: 10.1084/jem.144.3.726. View

12.

Lindstrom J, Lennon V, Seybold M, Whittingham S . Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann N Y Acad Sci. 1976; 274:254-74. DOI: 10.1111/j.1749-6632.1976.tb47691.x. View

13.

Lennon V, Lindstrom J, Seybold M . Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann N Y Acad Sci. 1976; 274:283-99. DOI: 10.1111/j.1749-6632.1976.tb47693.x. View

14.

Bartfeld D, Fuchs S . Immunological characterization of an irreversibly denatured acetylcholine receptor. FEBS Lett. 1977; 77(2):214-8. DOI: 10.1016/0014-5793(77)80237-8. View

15.

Lennon V, Peterson S, Schubert D . Neurectoderm markers retained in phenotypical skeletal muscle cells arising from a glial cell line. Nature. 1979; 281(5732):586-8. DOI: 10.1038/281586a0. View

16.

Towbin H, Staehelin T, Gordon J . Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979; 76(9):4350-4. PMC: 411572. DOI: 10.1073/pnas.76.9.4350. View

17.

Lennon V, Thompson M, Chen J . Properties of nicotinic acetylcholine receptors isolated by affinity chromatography on monoclonal antibodies. J Biol Chem. 1980; 255(10):4395-8. View

18.

Norcross N, Griffith I, Lettieri J . Measurement of acetylcholine receptor and anti-receptor antibodies by ELISA. Muscle Nerve. 1980; 3(4):345-9. DOI: 10.1002/mus.880030412. View

19.

Lennon V, LAMBERT E . Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann N Y Acad Sci. 1981; 377:77-96. DOI: 10.1111/j.1749-6632.1981.tb33725.x. View

20.

Kazim A, Atassi M . Structurally inherent antigenic sites. Localization of the antigenic sites of the alpha-chain of human haemoglobin in three host species by a comprehensive synthetic approach. Biochem J. 1982; 203(1):201-8. PMC: 1158211. DOI: 10.1042/bj2030201. View